Postmenopausal bleeding (PMB) raises significant concern in women, as it may signal early uterine malignancy. Consequently, all episodes of PMB require thorough investigation. Approximately 60–80% of ...
May 17, 2012 (San Diego, California) — A 1-year randomized study of postmenopausal women who took the new oral selective estrogen-receptor modulator (SERM) ospemifene (Ophena, Shionogi) for ...
Successful Treatment of Metastatic Renal Cell Carcinoma With a Nonmyeloablative Allogeneic Peripheral-Blood Progenitor-Cell Transplant: Evidence for a Graft-Versus-Tumor Effect PURPOSE: Tamoxifen is ...
Common causes of postmenopausal bleeding include atrophy and fibroids. Learn about risk factors, treatments, and when to ...
Any bleeding after menopause is abnormal, and a doctor should always check it. Vaginal atrophy is the most common cause of postmenopausal bleeding, which is often easily treatable. You may have polyps ...
Vaginal atrophy is a condition that can negatively impact the quality of life of many postmenopausal women. Local exogenous estrogen therapy can effectively alter the anatomic and pathophysiologic ...
Expert Rev of Obstet Gynecol. 2013;8(5):457-465. While treatments for vulvovaginal atrophy have often focused on the vagina, it is critical to address care for the vulvar vestibule as well. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results